James Lapworth

CBO at NanoSyrinx Ltd

Presenter

James is an experienced business development and technology commercialisation professional with over 15 years’ experience in fundraising, developing, partnering and out-licensing new technologies, particularly in the drug discovery, biotech and med-tech sectors. In his previous role at Warwick Ventures he established 6 new spinout companies which raised a total of £10m in seed stage equity financing between 2018-2021. In earlier roles, he established multiple early-stage discovery partnerships, including one of Europe’s first GSK Discovery Fast Track Challenge awards, leading to a collaborative partnership with GSK aimed at discovering new medicines for the treatment of non-Hodgkin’s lymphoma. James holds a PhD in Synthetic Chemistry and Regenerative Medicine from the University of Sheffield and is a Chartered Chemist.